PRODUCT DESCRIPTION
This in vitro diagnostic kit uses a chemiluminescent immunoassay with magnetic microparticles and a sandwich format to quantitatively measure total PSA in human serum or plasma. Requires 50 µL sample and delivers results in 10 minutes. Limit of quantification is 0.029 ng/mL. Storage at 2-8°C; avoid direct sunlight and freezing. CE certified. Ideal for early prostate disease detection, screening, and monitoring disease progression or therapy response.
PERFORMANCE
| Limit of Quantitation (LoQ): 0.029 ng/mL | ||
|---|---|---|
| Precision | Variability | Coefficient of variation, CV (%) |
| Repeatability | within run | <10% |
| Reproducibility | between-run/between-day | <10% |
| between-sites/between-operators | <10% | |
| between-lots | <10% | |
SPECIFICATION
| Principle | Sandwich-type chemiluminescent immunoassay |
| Assay format | Quantification |
| Rreaction time | 10 minutes |
| Sample type | Serum/Plasma |
| Sample volume | 50 μL |
| Detection unit | Relative light unit (RLU) |
| Storage | 2-8°C. Avoid exposure to direct sunlight. Do not freeze. |
| Certification | TFDA |
ORDERING INFORMATION
| Catalogue No. | Product |
|---|---|
| 4APSA02 | GB CL PSA |
| 4APSA1B | GB CL PSA-Control |
| 4APSA2B | GB CL PSA-Calibrator |